189 related articles for article (PubMed ID: 20863762)
21. Routine completion axillary lymph node dissection for positive sentinel nodes in patients undergoing mastectomy is not associated with improved local control.
Crawford JD; Ansteth M; Barnett J; Glissmeyer M; Johnson NG
Am J Surg; 2013 May; 205(5):581-4; discussion 584. PubMed ID: 23592166
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA.
Ross MI
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):77S-81S. PubMed ID: 11599908
[TBL] [Abstract][Full Text] [Related]
23. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
24. Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes.
Taras AR; Hendrickson NA; Lowe KA; Atwood M; Beatty JD
Am J Surg; 2010 May; 199(5):625-8. PubMed ID: 20466106
[TBL] [Abstract][Full Text] [Related]
25. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ
Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912
[TBL] [Abstract][Full Text] [Related]
26. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
Wang X; Zhao Y; Cao X
Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
[TBL] [Abstract][Full Text] [Related]
27. Is axillary dissection needed in node-positive breast cancer?
Greenberg CC; Bafford AC; Golshan M
Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
[TBL] [Abstract][Full Text] [Related]
28. [Axillary lymph node recurrence after sentinel lymph node biopsy for breast cancer].
Mathelin C; Salvador S; Guyonnet JL
J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):253-9. PubMed ID: 17317037
[TBL] [Abstract][Full Text] [Related]
29. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
30. When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node?
Suyoi A; Bains SK; Kothari A; Douek M; Agbaje O; Hamed H; Fentiman I; Pinder S; Purushotham AD
Eur J Cancer; 2014 Mar; 50(4):690-7. PubMed ID: 24331957
[TBL] [Abstract][Full Text] [Related]
31. Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?
Zippel D; Papa M
Arch Surg; 2003 Oct; 138(10):1159. PubMed ID: 14557139
[No Abstract] [Full Text] [Related]
32. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
33. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients.
Giuliano AE; Chung AP
Ann Surg; 2010 Apr; 251(4):601-3. PubMed ID: 20224365
[No Abstract] [Full Text] [Related]
35. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
36. The evolving role of axillary lymph node dissection in the modern era of breast cancer management.
Barry JM; Weber WP; Sacchini V
Surg Oncol; 2012 Jun; 21(2):143-5. PubMed ID: 21440434
[TBL] [Abstract][Full Text] [Related]
37. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Krynyckyi BR; Shim J; Lim I
Cancer; 2004 Feb; 100(3):654-5; author reply 655-6. PubMed ID: 14745886
[No Abstract] [Full Text] [Related]
38. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
39. Axillary vs sentinel lymph node dissection for invasive breast cancer.
Vuthaluru S; Srivastava A
JAMA; 2011 Jun; 305(22):2290; author reply 2290-1. PubMed ID: 21642675
[No Abstract] [Full Text] [Related]
40. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
